0A8E Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Xeris Biopharma Holdings Inc

Watchlist Manager

Watchlist

Price: 8.18 USD -1.68% Market Closed

Market Cap: $1.4B

	Xeris Biopharma Holdings Inc LSE:0A8E	US
Q	Qurate Retail Inc LSE:0A4G	US
T	Tialis Essential IT PLC F:U6M	UK
F	Fortune Brands Home & Security Inc XETRA:2FB	US
B	Bank of America Corp XETRA:NCB	US
	Thule Group AB STO:THULE	SE
	Aena SME SA MAD:AENA	ES
A	Atkore Inc F:AOA	US
	Persimmon PLC LSE:PSN	UK
	Clariane SE OTC:KRNMF	FR

Profitability Summary

Xeris Biopharma Holdings Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

85%

Strong 3Y Average Gross Margin

83%

Gross Margin is Increasing

82% > 85%

Low Operating Margin

Negative 3Y Average Operating Margin

-18%

Operating Margin is Increasing

-47% > 9%

Low Net Margin

Negative 3Y Average Net Margin

-27%

Net Margin is Increasing

-53% > 0%

Healthy Free Cash Flow Margin

10%

Negative 3Y Average Free Cash Flow Margin

-20%

Free Cash Flow Margin is Increasing

-57% > 10%

Negative ROE

-7%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-12%

ROIC is Increasing

-28% > 10%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.